Please provide your email address to receive an email when new articles are posted on . “PCOS patients are at increased risk of metabolic conditions, even patients who were in the non-obese range,” ...
NewcelX and Eledon Pharmaceuticals are collaborating to advance one of the few scalable approaches to a potential functional cure in Type 1 Diabetes, NCEL-101, as the flagship program and key long-ter ...
Aeon Biopharma (AEON) announced feedback from the FDA following a biosimilar biological product development Type 2a meeting. During the meeting, held in January, the FDA reviewed the company’s ...
Share on Pinterest Eating some foods in early childhood, like gluten-rich cereal, may increase a child’s risk of developing type 1 diabetes. Image credit: rachasuk/Getty Images. Type 1 diabetes is a ...
IRVINE, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE American: AEON), a biopharmaceutical company seeking accelerated and full-label U.S. market entry ...
AEON Biopharma (AEON) announced that the U.S. Food and Drug Administration has scheduled a Biosimilar Biological Product Development Type 2a meeting for ABP-450 on November 19, 2025, in line with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results